Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective
Sirtuins (SIRTs) are classified as class III histone deacetylases (HDACs), a family of enzymes that catalyze the removal of acetyl groups from the ε-N-acetyl lysine residues of histone proteins, thus counteracting the activity performed by histone acetyltransferares (HATs). Based on their involvemen...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2024-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_d5906f7cafd5488090cdfc20c7c9686f | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Naomi Scarano |e author |
| 700 | 1 | 0 | |a Chiara Brullo |e author |
| 700 | 1 | 0 | |a Francesca Musumeci |e author |
| 700 | 1 | 0 | |a Enrico Millo |e author |
| 700 | 1 | 0 | |a Santina Bruzzone |e author |
| 700 | 1 | 0 | |a Silvia Schenone |e author |
| 700 | 1 | 0 | |a Elena Cichero |e author |
| 245 | 0 | 0 | |a Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective |
| 260 | |b MDPI AG, |c 2024-05-01T00:00:00Z. | ||
| 500 | |a 10.3390/ph17050601 | ||
| 500 | |a 1424-8247 | ||
| 520 | |a Sirtuins (SIRTs) are classified as class III histone deacetylases (HDACs), a family of enzymes that catalyze the removal of acetyl groups from the ε-N-acetyl lysine residues of histone proteins, thus counteracting the activity performed by histone acetyltransferares (HATs). Based on their involvement in different biological pathways, ranging from transcription to metabolism and genome stability, SIRT dysregulation was investigated in many diseases, such as cancer, neurodegenerative disorders, diabetes, and cardiovascular and autoimmune diseases. The elucidation of a consistent number of SIRT-ligand complexes helped to steer the identification of novel and more selective modulators. Due to the high diversity and quantity of the structural data thus far available, we reviewed some of the different ligands and structure-based methods that have recently been used to identify new promising SIRT1/2 modulators. The present review is structured into two sections: the first includes a comprehensive perspective of the successful computational approaches related to the discovery of SIRT1/2 inhibitors (SIRTIs); the second section deals with the most interesting SIRTIs that have recently appeared in the literature (from 2017). The data reported here are collected from different databases (SciFinder, Web of Science, Scopus, Google Scholar, and PubMed) using "SIRT", "sirtuin", and "sirtuin inhibitors" as keywords. | ||
| 546 | |a EN | ||
| 690 | |a sirtuin | ||
| 690 | |a SIRT1 | ||
| 690 | |a SIRT2 | ||
| 690 | |a inhibitor | ||
| 690 | |a virtual screening | ||
| 690 | |a structure-activity relationship | ||
| 690 | |a Medicine | ||
| 690 | |a R | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pharmaceuticals, Vol 17, Iss 5, p 601 (2024) | |
| 787 | 0 | |n https://www.mdpi.com/1424-8247/17/5/601 | |
| 787 | 0 | |n https://doaj.org/toc/1424-8247 | |
| 856 | 4 | 1 | |u https://doaj.org/article/d5906f7cafd5488090cdfc20c7c9686f |z Connect to this object online. |